This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Metabolic engineering of CAR-T cells to overcome immune suppression
This is a test.
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
This is a test.
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
This is a test.
Implementation of patient-oriented Folate Receptor Alpha reporting
This is a test.
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
This is a test.
Uncovering targetable interactions of ovarian cancer cells
This is a test.
Exploring the role of PARG in DNA repair and cancer
This is a test.
Fallopian imaging and lavage for early-stage tubo-ovarian cancer detection
This is a test.
Syngeneic mouse models: tools to study immune-based treatments for ovarian cancer
This is a test.
Studying the evolution of high-grade serous ovarian cancer after targeted therapy
